USANA Health Sciences (NYSE:USNA) Releases FY 2025 Earnings Guidance

USANA Health Sciences (NYSE:USNA) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 2.350-3.000 for the period, compared to the consensus EPS estimate of 2.870. The company issued revenue guidance of $920.0 million-$1.0 billion, compared to the consensus revenue estimate of $934.5 million.

Analyst Ratings Changes

Several brokerages recently weighed in on USNA. DA Davidson raised their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research report on Thursday, January 2nd. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Finally, Sidoti downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

USANA Health Sciences Trading Up 1.6 %

USNA stock traded up $0.51 during midday trading on Wednesday, hitting $32.47. 255,514 shares of the company’s stock were exchanged, compared to its average volume of 147,559. USANA Health Sciences has a 12-month low of $30.13 and a 12-month high of $50.32. The stock has a market capitalization of $618.78 million, a price-to-earnings ratio of 11.45, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87. The firm has a 50 day moving average price of $33.65 and a 200-day moving average price of $36.64.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.49 by $0.15. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. On average, sell-side analysts forecast that USANA Health Sciences will post 2.45 EPS for the current fiscal year.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.